Het was een fantastische avond: het lustrumgala van stichting DON op vrijdag 16 september 2022. Er werd die avond een recordbedrag van 1,7 miljoen opgehaald voor de genezing van diabetes type 1. Daarvan is ten minste 1 miljoen euro toegekend aan de diabetes moonshot van RegMed XB, waarbinnen we hard werken aan genezing voor diabetes type 1 patiënten.

The fourth RegMed XB’s Annual Meeting was held in the Philips Stadion in Eindhoven on 6 and 7 July. They were successful and exciting days, marked by the positive vibe of interaction.

The urgency is high in the field of regenerative medicine. Promising therapies are in the pipeline from the lab to the patient, but a good infrastructure is needed to make this possible.

Mohammad Rezaeimoghaddam and Frans van de Vosse have published a paper with the title ”Continuum modeling of thrombus formation and growth under different shear rates” in the Journal of Biomechanics.

Interested in showcasing your BioPharma or Digital Health technologies to the Japanese audience?

River BioMedics, a drug discovery company using advanced 3D human cardiac models, today announced the closure of a 1.8 million Euro seed funding round to progress its research and innovation programs for cardiovascular disease targets and compounds.